We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
+36.26%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$138M
AUM Growth
+$34.8M
Cap. Flow
+$7.64M
Cap. Flow %
5.56%
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$7.17M
2
OPGN
OpGen, Inc
OPGN
+$2.92M

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$2.45M

Sector Composition

Rank Sector Weight
1 Healthcare 63.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKAO
1
DELISTED
Achaogen Inc
AKAO
$32.3M 23.51%
1,281,152
– –
BOLD
2
DELISTED
Audentes Therapeutics, Inc
BOLD
$30.8M 22.39%
1,806,832
– –
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
$25.9M 18.86%
407,416
– –
OCUL icon
4
Ocular Therapeutix
OCUL
$1.85B
$20.6M 14.95%
2,215,384
– –
IMDZ
5
DELISTED
Immune Design Corp.
IMDZ
$15M 10.92%
2,208,210
– –
VANI icon
6
Vivani Medical
VANI
$111M
$5.44M 3.95%
+187,207
New +$7.17M
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$4.51M 3.28%
1,048,601
– –
OPGN
8
DELISTED
OpGen, Inc
OPGN
$2.94M 2.14%
+26
New +$2.92M
GKOS icon
9
Glaukos
GKOS
$9.18B
– –
-71,428
Closed -$2.45M

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q1 2017 Portfolio in Review

As of Q1 2017, Versant Venture Management held 9 positions worth $138M, up 34% from $103M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management deployed $7.64M of net new capital in Q1 2017, opening 2 new positions. Its largest new stake was Vivani Medical: 187,207 shares worth $5.44M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 72% a quarter earlier.

On the sell side, the most notable exit was Glaukos, an estimated $2.45M sold.

  • Versant Venture Management's largest Q1 2017 buy was Vivani Medical: 187,207 shares worth $5.44M.
  • Versant Venture Management fully exited Glaukos in Q1 2017, selling an estimated $2.45M.
  • Versant Venture Management's ten largest holdings make up 100% of its $138M portfolio in Q1 2017.
  • Versant Venture Management opened 2 new positions and closed 1 in Q1 2017.
  • Versant Venture Management's portfolio value rose 34% quarter-over-quarter to $138M.

Based on Versant Venture Management's 13F filing for Q1 2017, filed 7 Apr 2017.